Target intelligence / Profile preview

Hemagglutinin H5N1 (HA H5N1)

Target
HA H5N1
Molecular classification
Viral surface glycoprotein, Class I fusion protein
01

Overview

Hemagglutinin (HA) is a homotrimeric glycoprotein on the surface of influenza A viruses, particularly the H5N1 strain. It mediates viral entry into host cells by binding to sialic acid receptors and facilitating membrane fusion. HA is a major target for neutralizing antibodies and antiviral drug development. The HA1 subunit binds to the receptor, while HA2 mediates membrane fusion. The cleavage site between HA1 and HA2 is a determinant of pathogenicity. Mutations, such as residue 226 changing from glutamine to leucine, can alter receptor specificity and facilitate cross-species transmission.

Other names
H5N1 HemagglutininHAH5 HemagglutininInfluenza A H5N1 Hemagglutinin
02

Mechanism of action

Neutralizing antibodies block virus attachment or inhibit post-binding steps such as membrane fusion. Antiviral drugs (developing) target hemagglutinin to prevent viral entry.

03

Biological functions

Receptor bindingMembrane fusionViral entryHost cell recognition
04

Disease associations

InfectionInfluenzaAvian influenzaPneumoniaMulti-organ failure
05

Safety considerations

Antigenic drift/shift leading to vaccine escapePotential for increased virulence through mutationsCross-species transmission risk
06

Interacting drugs

Neutralizing antibodies

2 more in the full profile.

Beyond the preview

Go deeper on Hemagglutinin H5N1 (HA H5N1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin H5N1 (HA H5N1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call